Martine Deprez: Leading with Mathematics, Listening, and Social Responsibility
FDA Approves Teclistamab Plus Daratumumab for Myeloma After ≥1 Prior Line — MajesTEC-3 Data Redefines the Standard of Care
Yvonne Awards 2026
ARCAGEN Trial at ESMO Sarcoma and Rare Cancers Congress 2026: Genomic Alterations and Access to Precision Therapies
Proud to Announce Our Partnership With GenomOncology and Belay Diagnostics - WeTrials
Dean Crowe: Rally Kids - Then and Now
Douglas Flora Shares Key Takeaways from NCODA’s Global Oncology Congress
Servier Acquires Day One Biopharmaceuticals for $2.5B, Betting on Tovorafenib and the Pediatric Glioma Frontier
The second edition of the Cancer Grand Challenges Conference Series, titled "Cancer and the Host," is set to convene from June 17–19, 2026, at the prestigious Royal Society in London. This landmark event, emerging from the Cancer Grand Challenges initiative co-founded by Cancer Research UK and the National Cancer Institute (NCI), redefines oncology by exploring […]
The Spatial Biology 2026 conference, part of the prestigious Cancer Grand Challenges series, is set to take place from September 1–3 at The Royal Society in London. Chaired by Professor Greg Hannon (CRUK Cambridge Institute), this landmark summit convenes global pioneers to explore the "inflection point" of spatial omics and 3D tumor mapping. Building on […]
